Amphiregulin in Cancer: New Insights for Translational Medicine.

Trends Cancer

Key Lab of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiaotong University School of Medicine, Shanghai 200031, China; Collaborative Innovation Center of Systems Biomedicine, Shanghai Jiaotong University School of Medicine, Shanghai 200240, China; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98195, USA. Electronic address:

Published: March 2016

Although there is a large body of literature regarding amphiregulin (AREG) in human cancer, most knowledge focuses on its cell-autonomous functions in epithelial malignancies. Recent studies revealed that AREG is also present in the tumor microenvironment (TME) and contributes to therapeutic resistance. We discuss emerging concepts of AREG tumor biology and highlight their implications for translational medicine.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2016.02.002DOI Listing

Publication Analysis

Top Keywords

translational medicine
8
areg tumor
8
amphiregulin cancer
4
cancer insights
4
insights translational
4
medicine large
4
large body
4
body literature
4
literature amphiregulin
4
amphiregulin areg
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!